Luye Pharma's SCLC Treatment Launch in HK and Macao

Luye Pharma has launched Zepzelca (lurbinectedin), a new drug for treating SCLC in Hong Kong and Macau.

Sun Pharma'ss Ankleshwar Unit: USFDA All-Clear, Hits 52-Week High

Shares of Sun Pharmaceutical Industries rose about 2%, hitting a 52-week high late on March 6, after the U.S. Food and Drug Administration (FDA) said it had granted full approval to Active Pharmaceutical Ingredient (API) from Ankleshwar Company).

Indian Healthcare Innovation Market: $60B by 2028 - Bain & Co

The Indian healthcare innovation market is anticipated to reach an estimated $60 billion by FY 2028, with Indian companies increasingly leveraging emerging technologies to add innovation vectors, including new business models

BlueRock Phase I Trial: Positive 18-Month Data for Parkinson's Treatment

Ayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned, independently operated subsidiary of Bayer AG, announced details of 18-month data from the phase I clinical trial for bemdaneprocel

Delhi HC Orders Health Ministry's Online Drug Sale Policy in 4 Months

The Delhi High Court has asked the Union Ministry of Health and Family Welfare to frame a policy of online sale of drugs within four months and warned that this would be the last and final opportunity for the Ministry for the same.

Venus Remedies Becomes a Recipient of Government's PLI Scheme

Venus Remedies Ltd has received its first disbursement of Rs 7.5 crore under the Central government's Production Linked Incentive (PLI) scheme for the fiscal year 2022-23, which accounts for 75% of the total incentive due to the company for the ye...

2024 HCLTech Grant Winners: Perinatal Mental Health & Childcare NGOs in Rural India

HCLFoundation, which drives the corporate social responsibility agenda of global technology company HCLTech in India, has announced the winner NGOs of the 2024 edition of its flagship program, the HCLTech Grant in rural India's

HCG: High Fluoride in Gutkha & Pan Masala Linked to Oral Pre-Cancer

Doctors at HCG Cancer Hospital have discovered a potential new cause of oral submucosal fibrosis (OSMF). This cancer causes oral tissues to thicken and restrict the opening of the mouth. Fluoride in gutkha

Positive Phase I Results for Cabotegravir Long-Acting Injectable

GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced positive findings from its phase I study showing that an investigational formulation

Sanskritech Introduces CDSCO-Approved Swandook Health Monitoring Bag

Sanskritech, a health-tech company in India backed by Mylab, has launched Swandook, an ultra-smart anytime health monitoring bag. Approved by CDSCO, Swandook represents a pioneering leap in healthcare technology, said the company

© 2024 India Pharma Outlook. All Rights Reserved.